Member Info for The_Paladin

Thank you Stan36. It sure is turning into a worse day than I thought earlier.

We are now up to 44m or thereabouts shares sold, with around 16m bought. A deliberate selloff if ever I saw one? Not all the large sells are showing. I expect that they will emerge later? This is what I call a slaughterhouse of a day, and hope that there won’t be more to follow?

Still two? One transaction was cancelled and then resubmitted? Still a lot of share dumping in a short time. This is proving to be a poor day for conviction based holders like myself.

Four early sells for a total of approximately £35K in the 0.35 - 0.37p range have apparently caused the sp to drop to this level? The buy volume just exceeded the sell volume the last time I looked, but the damage was already done.

I agree with Such’s assessment, but surely it must be a trader with plans to secure further gains elsewhere in the short term? Most probably not an investor with confidence in achieving a similar return from Capai within a short time frame? Unfortunately, this process may well continue on a daily basis until we have a concrete update from the company?

For Imaging Biometrics, it is probably business as usual in Wisconsin. They are earning sufficiently to pay their way. IB is going concern, but there is no indication of growth?

The GaM Ph1 trial continues to recruit patients. It is scheduled to conclude in December 2025. What part is IB's sponsorship playing in the trial? Is the company supplying equipment and other support to enable the trial to closely monitor patients' progress as their treatment evolves? The BTD application for this treatment was rejected, and may be re-submitted at an unspecified future date, when the company has sufficient supplementary evidence in place.

Dr.Al Musella's foundation is no doubt continuing its excellent work.

TEB. Brett Skelly, et al have ensured that their salaries have been paid through the annual placement. The company that financed the latter were presumably paid in shares, which were subsequently sold into the market at a low price? The net result is that the share price has crashed and burned to an all time low, with little sign of recovery on the horizon?

Imaging Biometrics are a team of humanists - very good people. The fact that they recruit young talent from a nearby Franciscan University speaks volumes, as did the quarterly reviews that MS used to publish.

The above facts sum up our current situation. My concern as an investor is where is the growth and future prosperity of IBAI going to emerge from? When is this going to happen? We are currently at an all time low. The trading of our shares has virtually stopped. Our MCap is £1.86m. What are our CEO and the other company executives doing to improve matters? It would be good to receive some answers, and soon! GLA.

The recent warrants sale has apparently concluded, according to the number of shares in circulation. The morning share selling frenzy hasn’t calmed down though. My take on this is that traders looking for quick returns continue to move their capital elsewhere in response to new developments?

Although I bought in way too soon, I am holding for the foreseeable future. Concrete information is now needed from the company to effect a turnaround to the current selling trend. In my opinion it will come eventually. GLA.

Some excellent responses to an earlier query. I benefited a great deal from reading this information in summary form.

All worthwhile investments take time to mature. Imagine if early Apple investors had displayed a similar level of impatience as some of today’s “rainbow chasers” ? Apple endured a bumpy ride before Steve Jobs famously returned from exile, and oversaw the development of some market changing products. I am expecting innovation at a similar level from Capai, and realise that these will also take time to come to the fore.

My thanks to several contributors on what has become a first rate discussion forum.

The principal discussion points are warrant sales, and viable incoming AI-based businesses. Unfortunately, it isn’t possible to validate any information on either, until we receive an announcement from the company.

I chose to add another 320K at a shade under 0.48p incl. earlier this morning. I am prepared to patiently await an update, whenever it arrives? I remain fairly optimistic, but one never knows? Capai has presented a detailed, financed business plan, and there are no major concerns as the current new business negotiations, and warrant transactions continue to proceed. GLA.

I agree xv. IB have been showing their technology on twitter/X for several years. I still recall TEB’s “Wow” response. It seems evident that their attempts to attract market attention, including the use of an YouTube channel have not achieved the desired results.

Following last week’s RNS, it seems that we will need to wait until next December when the Ph1 trial concludes for further update?

Currently no one is buying IBAI shares. Some apparently disenchanted investors have been selling chunks of stock at all time low share prices, which have reduced the share price by >7% since the recent rebrand.

I agree with investors who maintain that the BOD need to step up. I am unaware of their strategy moving forward? A placement to pay the salaries and expenses of the IQAI directors (not MS), and a failed bid to upgrade a product designation have together more than halved the already struggling share price.

I hope that semantic/TEB is aware of the fact that his actions over the last 18 months appear to have reduced the company to today’s all time low MCap!

GLA. At this point, we need it!

The sea of red currently on display are buys. I have just bought 400K shares at the same price. My broker’s website suggests that the share price may have bottomed? Let us see what happens this week? GLA.

I agree with Tyke.

Imaging Biometrics is a quality company with an ably led team of high quality individuals.

https://www.imagingbiometrics.com/more-information/about-us/

There is a close connection, through one of our founders, to the Medical College of Wisconsin.

https://www.mcw.edu/mcwknowledge/mcw-stories/innovative-glioblastoma-treatment-advances-thanks-to-groundbreaking-research-and-community-support

A phase 1 trial of a glioblastoma treatment at MCU, sponsored by IBAI is nearing completion.

It beggars belief that a company of this quality is valued at £2m. Surely there is more inherent value than this in the company’s IP alone?

IB has existed for more than 20 years. Do we lack the business acumen to monetise our undoubtedly high quality technologies? Or are we competing against other companies with similar quality , but with better approaches to marketing and retail? The continuous IB efforts to describe the high quality of our products online has achieved little in terms of revenue? Similarly, with their online progress reports on the glioblastoma trial? It is as though the company’s Herculean efforts, and progress made, over two decades, has gone virtually unnoticed?

The company would truly benefit from the presence of a strong business leader with the right connections to move the IBAI forward! It does feel that despite our undoubted high level products, and personnel, we have remained at ground zero in terms of our valuation for 20 years. Semantic is right that with their online progress rebranding, there is a blank slate, free from past IQAI mistakes, for new investors to judge the company. However without a forward impetus, driven by strong leadership, we might just remain trading water, and operating a share dilution placement each year to pay the salaries of the previous IQAI team, who remain at the helm.

GLA.

All buys so far today. There is a small upward buy/sell shift to 0.809p/0.773p. Is there any news due this week? Some tangible input would be more than welcome in order to initiate further interest in our technology and Ph1 trial. I am surprised that we have been virtually ignored for so long. GLA.

Definitely buys this morning. The current buy price for this number of shares remains at 0.7999p, whereas the sell price for a similar number is 0.7656p. The 0.85p/0.75p quoted is inaccurate; the trading range is a lot narrower than 13.33%.

Nothing gained today, but at least we have moved away from NT - even for tiny sells a few days ago - for the time being. GLA.

Tyke,

Either way, I would have expected a different share price for both transactions? Presumably, there is an explanation, but I don’t have one? ATB.

I always appreciate the information that max regularly shares for the positive messages constantly relayed by IB. I fully understand and share the company’s and investors’ frustration as IBAI’s latent value is not reflected in our present MCap?

Phil was spot on concerning the 250K share trades

(sells ) last week. I note that there are two further trades , in close proximity, of 300K shares @ 0.80p this morning. It is odd to see largish transactions at the quoted share price - presumably buys, although I would have expected a higher buy price?

Phil. Unfortunately, they are quoted as two separate sells, with a slightly different sell price on the London Stock Exchange site.

That is my major concern here. Investors are selling large chunks of IBAI shares, with nothing incoming from the company to offset the process. How long has it been since we had a piece of information, which promoted investment, and brought about a rise in the shares price?

We are still suffering from the damage to the share price from TEB’s huge share sales during early 2024. No doubt, he had personal reasons for this, but a massive selloff from a company’s CEO is without doubt negatively perceived by potential incoming investors.

There has been no stimulus to the share price since then. Both placements, effectively diluting our investment have barely covered the wages of the principal players (excluding MS, that is. From the balance sheet, MS wasn’t paid anything from this source).

In short, the company needs significant news to lift us from our current hiatus. Otherwise the company’s share price may fall further! GLA.

Semantic has a point. The term ‘meatless anodyne’ was recently used to describe Keir Starmer’s speech on the government’s proposed increase to the country’s defence budget.

There is little value in promoting our current situation until there is something significant to add to the trinity of technology sales, Ph1 trial outcome, and/or interest from a significant partner.

There may well be reasons why information of this kind cannot be disclosed at present? However, recent IBAI trades have shown that some investors’ patience is wearing thin here. Recent massive gains in the shares of small companies have stirred up a lot of interest in the AIM casino. I have decided to remain with my IBAI investment, as I, rightly or wrongly, foresee future value in this company. Provided there is no further damaging dabbling from a certain party, that is!

There doesn’t seem to be anything happening ATM apart from the selling of (presumably) free shares at historic low prices.

I recall the time that RMS (a former TEB company) rebranded with a cool new name and website. TEB had departed by then, so the ensuing fall to oblivion had nothing whatsoever to do with him.

However, it is a worrying precedent as no news heralding a share price increase has emerged from this company for far too long! I am seriously considering selling my shares, and receiving some capital from the sale - albeit at a big loss! How many of us now wish we had sold at c.5p at the end of 2023? There was little indication then that we were headed downward to our current dire straits!

I am trying to work out where future revenues will come from? Sales of market leading technology? Successful Ph1 trial outcome? A buyout by a large entity? The market is decidedly unimpressed by what is currently on offer, and some stimulus is desperately needed.

GLA - we need it.

I couldn't dummy sell 5000 IBAI shares this morning except by negotiated trade. We are back where we were a few days ago. The company's rebrand appears to have gone unnoticed. IMHO yesterday's abrupt selloff was either someone in need of funds, as Tyke stated, or else a trader looking for a better opportunity.We remain totally under investors' radar, and are in need of some action from the company.

I looked at our imaging products on Blackford's platform last night. They are of a high quality and are well displayed and explained, as is the case on IB's current website. Clearly more is needed from the company if they are to achieve significant sales. Further there are a large number of diagnostic imaging products utilising AI on the market. This may partly explain our lack of impact?

Unfortunately, there is no discernible change in our market value. Based on "dummy" trades of 300K shares, 0.8325p to buy, and 0.805p to sell.

At least some liquidity has been restored. Last week, it was only possible to sell 20K shares through a negotiated trade.

Our share price hasn't fallen the 0.85p quoted was on the basis of a tiny UT yesterday afternoon. My broker retained has retained the 0.825p sp for some time.